The Bioventus research and development group led a cross functional team to develop OSTEOMATRIX+, which has more unique handling properties, including improved moldability, flexibility and versatility, than its predecessor.
“OSTEOMATRIX+ represents the first of several next generation products that will be added to the Bioventus portfolio in the next five years,” said Tony Bihl, CEO of Bioventus. “We will provide more diverse orthobiologic offerings for hospitals and efficacious solutions for both surgeons and their patients, as we continue to grow and serve these markets.”
OSTEOMATRIX+ is available now from distributors nationwide.
Bioventus is an orthobiologics company that delivers products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The orthobiologic products from Bioventus include offerings for osteoarthritis, surgical and non-surgical bone healing.